Francesco Musella
About
In The Last Decade
Francesco Musella
13 papers receiving 205 citations
Peers
Comparison fields: 5 of 40
- Molecular Biology 162
- Cardiology and Cardiovascular Medicine 36
- Plant Science 34
- Radiology, Nuclear Medicine and Imaging 17
- Genetics 13
Countries citing papers authored by Francesco Musella
This map shows the geographic impact of Francesco Musella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Musella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Musella more than expected).
Fields of papers citing papers by Francesco Musella
This network shows the impact of papers produced by Francesco Musella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Musella. The network helps show where Francesco Musella may publish in the future.
Co-authorship network of co-authors of Francesco Musella
This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Musella. A scholar is included among the top collaborators of Francesco Musella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Musella. Francesco Musella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 37 | |
| 4 | 3 | |
| 5 | 13 | |
| 6 | 8 | |
| 7 | 32 | |
| 8 | 35 | |
| 9 | 3 | |
| 10 | 12 | |
| 11 | 16 | |
| 12 | 23 | |
| 13 | 15 | |
| 14 | High-Avidity Cytotoxic T Lymphocytes Specific for a New Peptide Derived From Preferentially Expressed Antigen of Melanoma (Prame) Can Target Leukemic Precursor Cells. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.